USANA HEALTH SCIENCES INC
For the period ended Sep 27, 2025. Filed Nov 5, 2025.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Sep 27, 2025 · Filed Nov 5, 2025
USNA$13.10-5.4%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Condensed Consolidated Statements of Comprehensive Income
CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS)
| Three Months Ended | Nine Months Ended | |||
|---|---|---|---|---|
| September 27,2025 | September 28,2024 | September 27,2025 | September 28,2024 | |
| Net sales | $213,670 | $200,221 | $699,057 | $640,890 |
| Cost of sales | 48,815 | 39,257 | 151,444 | 122,659 |
| Gross profit | 164,855 | 160,964 | 547,613 | 518,231 |
| Operating expenses: | ||||
| Brand Partner incentives | 77,684 | 84,068 | 254,709 | 270,197 |
| Selling, general and administrative | 85,947 | 61,295 | 259,291 | 189,920 |
| Total operating expenses | 163,631 | 145,363 | 514,000 | 460,117 |
| Earnings from operations | 1,224 | 15,601 | 33,613 | 58,114 |
| Other income (expense): | ||||
| Interest income | 578 | 3,142 | 1,920 | 8,581 |
| Interest expense | (49) | (49) | (719) | (152) |
| Other, net | 41 | (86) | 2,536 | (621) |
| Other income (expense), net | 570 | 3,007 | 3,737 | 7,808 |
| Earnings before income taxes | 1,794 | 18,608 | 37,350 | 65,922 |
| Income taxes | 8,456 | 8,001 | 24,278 | 28,346 |
| Net (loss) earnings | (6,662) | 10,607 | 13,072 | 37,576 |
| Less: Net (loss) earnings attributable to redeemable noncontrolling interest | (140) | — | 537 | — |
| Net (loss) earnings attributable to USANA | $(6,522) | $10,607 | $12,535 | $37,576 |
| (Loss) earnings per common share attributable to USANA | ||||
| Basic | $(0.36) | $0.56 | $0.67 | $1.97 |
| Diluted | $(0.36) | $0.56 | $0.67 | $1.96 |
| Weighted average common shares outstanding | ||||
| Basic | 18,293 | 19,078 | 18,618 | 19,108 |
| Diluted | 18,293 | 19,083 | 18,671 | 19,181 |
| Comprehensive income (loss): | ||||
| Net (loss) earnings | $(6,662) | $10,607 | $13,072 | $37,576 |
| Other comprehensive income (loss), net of tax: | ||||
| Foreign currency translation adjustment | 112 | 7,654 | 3,910 | 706 |
| Tax (expense) benefit related to foreign currency translation adjustment | (52) | (845) | (529) | (710) |
| Other comprehensive income (loss), net of tax | 60 | 6,809 | 3,381 | (4) |
| Comprehensive income (loss) | (6,602) | 17,416 | 16,453 | 37,572 |
| Less: comprehensive income (loss) attributable to redeemable noncontrolling interest | (140) | — | 537 | — |
| Comprehensive income (loss) attributable to USANA | $(6,462) | $17,416 | $15,916 | $37,572 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.